"Neoplasm Invasiveness" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ability of neoplasms to infiltrate and actively destroy surrounding tissue.
| Descriptor ID |
D009361
|
| MeSH Number(s) |
C04.697.645 C23.550.727.645
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Invasiveness".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Invasiveness".
This graph shows the total number of publications written about "Neoplasm Invasiveness" by people in this website by year, and whether "Neoplasm Invasiveness" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 1 | 2 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 4 | 4 |
| 2000 | 0 | 8 | 8 |
| 2001 | 1 | 10 | 11 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 15 | 15 |
| 2004 | 2 | 8 | 10 |
| 2005 | 3 | 14 | 17 |
| 2006 | 1 | 13 | 14 |
| 2007 | 4 | 19 | 23 |
| 2008 | 4 | 18 | 22 |
| 2009 | 1 | 16 | 17 |
| 2010 | 0 | 17 | 17 |
| 2011 | 2 | 16 | 18 |
| 2012 | 1 | 20 | 21 |
| 2013 | 4 | 23 | 27 |
| 2014 | 3 | 22 | 25 |
| 2015 | 1 | 25 | 26 |
| 2016 | 2 | 24 | 26 |
| 2017 | 2 | 29 | 31 |
| 2018 | 1 | 19 | 20 |
| 2019 | 0 | 20 | 20 |
| 2020 | 0 | 17 | 17 |
| 2021 | 2 | 16 | 18 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 6 | 6 |
| 2024 | 3 | 12 | 15 |
| 2025 | 0 | 17 | 17 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Invasiveness" by people in Profiles.
-
MiR-200c restoration inhibits FOXP3 and metastatic spread in breast cancer: evidence from in vitro and in vivo models. BMC Cancer. 2026 Feb 14; 26(1).
-
Alopecia following single-dose postoperative intravesical gemcitabine in nonmuscle-invasive bladder cancer: A multi-institutional case series. Urol Oncol. 2026 Mar; 44(3):110984.
-
Forward genetic screening in engineered colorectal cancer organoids identifies regulators of metastasis. Proc Natl Acad Sci U S A. 2025 Nov 18; 122(46):e2510910122.
-
AGA Clinical Practice Update on Endoscopic Resection for Early Colorectal Cancer: Commentary. Gastroenterology. 2025 Dec; 169(7):1558-1564.
-
Transphyseal tumor extension on initial magnetic resonance imaging (MRI) correlates with metastases in pediatric extremity osteosarcoma. Skeletal Radiol. 2026 Mar; 55(3):525-531.
-
Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group. Eur Urol Oncol. 2025 Dec; 8(6):1685-1695.
-
Dysregulated mitochondrial energy metabolism drives the progression of mucosal field effects to invasive bladder cancer. J Pathol. 2025 Nov; 267(3):329-346.
-
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer. J Clin Oncol. 2025 Nov 10; 43(32):3536-3544.
-
Cisplatin-ineligible patients with muscle-invasive bladder cancer demonstrate poor long-term survival following immediate radical cystectomy. BJU Int. 2026 Jan; 137(1):181-188.
-
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies. Nat Rev Urol. 2025 12; 22(12):846-861.